| Primary |
| Alopecia |
41.0% |
| Androgenetic Alopecia |
38.4% |
| Male Pattern Baldness |
8.4% |
| Hypertension |
2.0% |
| Product Used For Unknown Indication |
1.4% |
| Diabetes Mellitus |
1.4% |
| Depression |
1.0% |
| Hyperuricaemia |
0.9% |
| Prophylaxis |
0.9% |
| Hair Transplant |
0.5% |
| Upper Respiratory Tract Inflammation |
0.5% |
| Seborrhoeic Dermatitis |
0.5% |
| Alopecia Areata |
0.5% |
| Hyperlipidaemia |
0.5% |
| Angina Pectoris |
0.4% |
| Benign Prostatic Hyperplasia |
0.4% |
| Thrombosis Prophylaxis |
0.4% |
| Hair Loss |
0.4% |
| Gastroenteritis |
0.3% |
| Hypercholesterolaemia |
0.3% |
|
| Sexual Dysfunction |
45.4% |
| Erectile Dysfunction |
8.1% |
| Libido Decreased |
6.1% |
| Drug Ineffective |
5.1% |
| Hepatic Function Abnormal |
3.4% |
| Depression |
3.3% |
| Prostate Cancer |
3.3% |
| Testicular Pain |
3.0% |
| Loss Of Libido |
2.8% |
| Anxiety |
2.6% |
| Semen Volume Decreased |
2.4% |
| Cognitive Disorder |
2.1% |
| Liver Disorder |
1.8% |
| Wrong Technique In Drug Usage Process |
1.7% |
| Transmission Of Drug Via Semen |
1.6% |
| Drug Exposure During Pregnancy |
1.5% |
| Ejaculation Disorder |
1.5% |
| Paternal Drugs Affecting Foetus |
1.5% |
| Gynaecomastia |
1.4% |
| Alopecia |
1.4% |
|
| Secondary |
| Alopecia |
39.7% |
| Androgenetic Alopecia |
32.8% |
| Male Pattern Baldness |
10.3% |
| Hyperuricaemia |
1.9% |
| Benign Prostatic Hyperplasia |
1.6% |
| Drug Use For Unknown Indication |
1.6% |
| Prophylaxis |
1.6% |
| Alopecia Areata |
1.3% |
| Hair Transplant |
1.3% |
| Hepatitis B |
0.9% |
| Hypertension |
0.9% |
| Mental Disorder |
0.9% |
| Product Used For Unknown Indication |
0.9% |
| Abdominal Pain |
0.6% |
| Acne |
0.6% |
| Atrial Fibrillation |
0.6% |
| Cystitis |
0.6% |
| Depression |
0.6% |
| Diabetes Mellitus |
0.6% |
| Drug Exposure During Pregnancy |
0.6% |
|
| Wrong Technique In Drug Usage Process |
16.4% |
| Hepatic Function Abnormal |
12.3% |
| Sexual Dysfunction |
12.3% |
| Libido Decreased |
8.2% |
| Blood Bilirubin Increased |
6.6% |
| Dizziness |
4.1% |
| Amyotrophic Lateral Sclerosis |
3.3% |
| Anxiety |
3.3% |
| Drug Ineffective |
3.3% |
| Erectile Dysfunction |
3.3% |
| Liver Disorder |
3.3% |
| Prostate Cancer |
3.3% |
| Semen Volume Decreased |
3.3% |
| Blood Follicle Stimulating Hormone Decreased |
2.5% |
| Disturbance In Attention |
2.5% |
| Drug Exposure During Pregnancy |
2.5% |
| Faeces Pale |
2.5% |
| Insomnia |
2.5% |
| Orchitis |
2.5% |
| Tinnitus |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.6% |
| Drug Use For Unknown Indication |
12.9% |
| Alopecia |
12.3% |
| Hypertension |
5.7% |
| Crohn's Disease |
4.4% |
| Erectile Dysfunction |
3.7% |
| Psoriasis |
3.5% |
| Anxiety |
3.3% |
| Smoking Cessation Therapy |
3.3% |
| Blood Cholesterol Increased |
3.0% |
| Prophylaxis |
3.0% |
| Acne |
2.5% |
| Migraine |
2.5% |
| Depression |
2.3% |
| Asthma |
2.0% |
| Multiple Myeloma |
1.8% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Atrial Fibrillation |
1.6% |
| High Density Lipoprotein Decreased |
1.6% |
| Multiple Sclerosis |
1.6% |
|
| Weight Decreased |
9.3% |
| Drug Ineffective |
7.8% |
| Flushing |
7.8% |
| Pruritus |
7.8% |
| Alopecia |
7.0% |
| Rhabdomyolysis |
7.0% |
| Urticaria |
5.4% |
| Weight Increased |
5.4% |
| Pain In Extremity |
4.7% |
| Rash |
4.7% |
| Cerebrovascular Accident |
3.9% |
| Vision Blurred |
3.9% |
| Visual Acuity Reduced |
3.9% |
| Blood Creatinine Increased |
3.1% |
| Nausea |
3.1% |
| Off Label Use |
3.1% |
| Pain |
3.1% |
| Proctitis |
3.1% |
| Psoriasis |
3.1% |
| Toxic Skin Eruption |
3.1% |
|
| Interacting |
| Alopecia |
50.0% |
| Antiretroviral Therapy |
50.0% |
|
|
